Preface
Analytical Cellular Pathology has a longstanding history of focusing on the quantitative morphologic aspects of pathology. We are now embarking on a substantial extension of this concept in order to serve as a forum for communication of scientific research in the broader area of biophysical pathology as well as quantitatively oriented molecular pathology. We hope to highlight research involving emerging, state-of-the-art technologies.
With this repurposing of the journal, we hope to make it not only a vehicle for the dissemination of scientific discovery via both full-length papers and brief communications but also a means of promoting additional interest in this area of research. With this in mind, we will increase the number of reviews and mini-reviews. Specifically, we are introducing a section titled "Modern Trends in Imaging" that will consist of a series of reviews on modern modalities of visual analysis. From time to time, we will invite commentaries inspired by papers of special significance or emerging new concepts in the field.
The evolution of anatomic pathology from a discipline based upon direct observation of visual light images to multi-modality computer-intensive analysis is entering a phase of accelerated growth. However, the technological underpinnings are developing more rapidly than our ability to exploit them for both diagnostic and experimental pathology, and pathologists have proved not as ready to embrace novel technologies as radiologists or indeed other clinical professions with access to imaging modalities.
Hand in hand with the emerging of this modern armamentarium for the study of abnormal tissue structure and function has come the realization that the cell itself can be understood and studied at the level of the physical processes by which it interacts with its environment. This has been long recognized in the field of biophysics, but increasingly attention is being focused on such mechanistic aspects of pathogenesis as well.
Although much of the journal in the past has been devoted to oncology, we wish to consider the whole spectrum of disease including not only cancer, but also infectious, cardiovascular, autoimmune, vascular, genetic and metabolic disease. Papers should be based on novel concepts and methodologies, as well as the novel use of existing methodologies. Traditional molecular mechanistic studies are also appropriate, but these should be quantitative in nature. In addition to hypothesis-testing studies, hypothesis-generating observational studies are also welcome. Finally, mathematical models of disease processes are acceptable, especially when they lead to testable predictions.
Just as the flourishing of molecular biology has led to a paradigm shift that has rejuvenated our field, the convergence of biomedicine, bioengineering, and sophisticated new tools of mathematical analysis will move us towards a more quantitative and analytic discipline. It is our intention to become the leading journal in this field, and to be accessible not only to cell and molecular biologists and pathologists, but also to physicists and bioengineers.
Last, but not least, it is important for us to hear from the Journal's readers and authors as to how we can ensure that the journal best suits their needs. In order for us to succeed, we will have to make it truly international in scope, so that geographic as well as conceptual barriers can be eliminated. 
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